The consequences of poor dietary patterns on the proliferation of non-alcoholic fatty liver disease

References

• Abenavoli, L., & Peta, V. (2014). Role of adipokines and cytokines in non-alcoholic fatty liver disease. Reviews on Recent Clinical Trials, 9(3), 1–18. https://doi.org/10.2174/1574887109666141216102458
   PubMedGoogle Scholar
• Adams, L. A., Angulo, P., & Lindor, K. D. (2005). Nonalcoholic fatty liver disease. CMAJ, 172(7), 899–905. https://doi.org/10.1503/cmaj.045232
   PubMed Web of Science ®Google Scholar
• Akhlaghi, M., Ghasemi-Nasab, M., & Riasatian, M. (2020). Mediterranean diet for patients with non-alcoholic fatty liver disease, a systematic review and meta-analysis of observational and clinical investigations. Journal of Diabetes and Metabolic Disorders, 19(1), 575–584. https://doi.org/10.1007/s40200-019-00475-2
   PubMed Web of Science ®Google Scholar
• Al-Busafi, S. A., Bhat, M., Wong, P., Ghali, P., & Deschenes, M. (2012). Antioxidant therapy in nonalcoholic steatohepatitis. Hepatitis Research and Treatment, 2012, 947575–947578. https://doi.org/10.1155/2012/947575
   PubMedGoogle Scholar
• Amengual, J., Ribot, J., Bonet, M. L., & Palou, A. (2010). Retinoic acid treatment enhances lipid oxidation and inhibits lipid biosynthesis capacities in the liver of mice. Cellular Physiology and Biochemistry, 25(6), 657–666. https://doi.org/10.1159/000315085
   PubMedGoogle Scholar
• Anania, C., Perla, F. M., Olivero, F., Pacifico, L., & Chiesa, C. (2018). Mediterranean diet, and nonalcoholic fatty liver disease. World Journal of Gastroenterology, 24(19), 2083–2094. https://doi.org/10.3748/wjg.v24.i19.2083
   PubMed Web of Science ®Google Scholar
• Arroyave-Ospina, J. C., Wu, Z., Geng, Y., & Moshage, H. (2021). Role of oxidative stress in the pathogenesis of non-alcoholic fatty liver disease: Implications for prevention and therapy. Antioxidants, 10(2), 174. https://doi.org/10.3390/antiox10020174
   Web of Science ®Google Scholar
• Arslan, N. (2014). Obesity, fatty liver disease, and intestinal microbiota. World Journal of Gastroenterology, 20(44), 16452–16463. https://doi.org/10.3748/wjg.v20.i44.16452
   PubMed Web of Science ®Google Scholar
• Asbaghi, O., Choghakhori, R., Ashtary-Larky, D., & Abbasnezhad, A. (2020). Effects of the Mediterranean diet on cardiovascular risk factors in non-alcoholic fatty liver disease patients: a systematic review and meta-analysis. Clinical Nutrition ESPEN, 37, 148–156. https://doi.org/10.1016/j.clnesp.2020.03.003
   PubMed Web of Science ®Google Scholar
• Banini, B. A., & Sanyal, A. J. (2019). Vitamin E in Nonalcoholic Fatty Liver Disease. In: Weber, P., Birringer, M., Blumberg, J., Eggersdorfer, M., Frank, J. (Eds.), Vitamin E in human health. nutrition and health. Humana Press. https://doi.org/10.1007/978-3-030-05315-4_23
   Google Scholar
• Berná, G., & Romero‐Gomez, M. (2020). The role of nutrition in non‐alcoholic fatty liver disease: pathophysiology and management. Liver International, 40(S1), 102–108. https://doi.org/10.1111/liv.14360
   PubMedGoogle Scholar
• Brøns, C., Jensen, C. B., Storgaard, H., Hiscock, N. J., White, A., Appel, J. S., Jacobsen, S., Nilsson, E., Larsen, C. M., Astrup, A., Quistorff, B., & Vaag, A. (2009). Impact of short‐term high‐fat feeding on glucose and insulin metabolism in young healthy men. The Journal of Physiology, 587(Pt 10), 2387–2397. https://doi.org/10.1113/jphysiol.2009.169078
   PubMed Web of Science ®Google Scholar
• Browning, J. D., Baker, J. A., Rogers, T., Davis, J., Satapati, S., & Burgess, S. C. (2011). Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction. The American Journal of Clinical Nutrition, 93(5), 1048–1052. https://doi.org/10.3945/ajcn.110.007674
   PubMed Web of Science ®Google Scholar
• Cai, H., Qin, Y.-L., Shi, Z.-Y., Chen, J.-H., Zeng, M.-J., Zhou, W., Chen, R.-Q., & Chen, Z.-Y. (2019). Effects of alternate-day fasting on body weight and dyslipidemia in patients with non-alcoholic fatty liver disease: a randomized controlled trial. BMC Gastroenterology, 19(1), 219. https://doi.org/10.1186/s12876-019-1132-8
   PubMed Web of Science ®Google Scholar
• Cañete, N. G., & Agüero, S. D. (2014). Soya isoflavones and evidences on cardiovascular protection. Nutricion Hospitalaria, 29(6), 1271–1282.
   PubMed Web of Science ®Google Scholar
• Casas, R., Sacanella, E., & Estruch, R. (2014). The immune protective effect of the Mediterranean diet against chronic low-grade inflammatory diseases. Endocrine, Metabolic & Immune Disorders Drug Targets, 14(4), 245–254. https://doi.org/10.2174/1871530314666140922153350
   PubMed Web of Science ®Google Scholar
• Cherkaoui-Malki, M., Surapureddi, S., El-Hajj, H. I., Vamecq, J., & Andreoletti, P. (2012). Hepatic steatosis and peroxisomal fatty acid beta-oxidation. Current Drug Metabolism, 13(10), 1412–1421. https://doi.org/10.2174/138920012803762765
   PubMed Web of Science ®Google Scholar
• Chiavaroli, L., Viguiliouk, E., Nishi, S. K., Blanco Mejia, S., Rahelić, D., Kahleová, H., Salas-Salvadó, J., Kendall, C. W., & Sievenpiper, J. L. (2019). DASH dietary pattern and cardiometabolic outcomes: an umbrella review of systematic reviews and meta-analyses. Nutrients, 11(2), 338. https://doi.org/10.3390/nu11020338
   PubMed Web of Science ®Google Scholar
• Chiu, T. H., Lin, M. N., Pan, W. H., Chen, Y. C., & Lin, C. L. (2018). Vegetarian diet, food substitution, and nonalcoholic fatty liver. Tzu-Chi Medical Journal, 30(2), 102–109. https://doi.org/10.4103/tcmj.tcmj_109_17
   Google Scholar
• Cortez-Pinto, H., Jesus, L., Barros, H., Lopes, C., Moura, M. C., & Camilo, M. E. (2006). How different is the dietary pattern in non-alcoholic steatohepatitis patients? Clinical Nutrition, 25(5), 816–823. https://doi.org/10.1016/j.clnu.2006.01.027
   PubMed Web of Science ®Google Scholar
• Cunha, G. M., Guzman, G., Correa De Mello, L. L., Trein, B., Spina, L., Bussade, I., Marques Prata, J., Sajoux, I., & Countinho, W. (2020). Efficacy of a 2-month Very Low-Calorie Ketogenic Diet (VLCKD) compared to a standard low-calorie diet in reducing visceral and liver fat accumulation in patients with obesity. Frontiers in Endocrinology, 11, 607. https://doi.org/10.3389/fendo.2020.00607
   PubMed Web of Science ®Google Scholar
• D’Abbondanza, M., Ministrini, S., Pucci, G., Nulli Migliola, E., Martorelli, E.-E., Gandolfo, V., Siepi, D., Lupattelli, G., & Vaudo, G. (2020). Very low-carbohydrate ketogenic diet for the treatment of severe obesity and associated nonalcoholic fatty liver disease: the role of sex differences. Nutrients, 12(9), 2748. https://doi.org/10.3390/nu12092748
   PubMed Web of Science ®Google Scholar
• Dekker, M. J., Su, Q., Baker, C., Rutledge, A. C., & Adeli, K. (2010). Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. American Journal of Physiology, Endocrinology and Metabolism, 299(5), E685–94. https://doi.org/10.1152/ajpendo.00283.2010
   PubMed Web of Science ®Google Scholar
• Dhibi, M., Brahmi, F., Mnari, A., Houas, Z., Chargui, I., Bchir, L., Gazzah, N., Alsaif, M. A., & Hammami, M. (2011). The intake of high fat diet with different trans fatty acid levels differential induces oxidative stress and non-alcoholic fatty liver disease (NAFLD) in rats. Nutrition & Metabolism, 8(1), 65. https://doi.org/10.1186/1743-7075-8-65
   PubMedGoogle Scholar
• Ditano-Vázquez, P., Torres-Peña, J. D., Galeano-Valle, F., Pérez-Caballero, A. I., Demelo-Rodríguez, P., Lopez-Miranda, J., Katsiki, N., Delgado-Lista, J., & Alvarez-Sala-Walther, L. A. (2019). The fluid aspect of the Mediterranean diet in the prevention and management of cardiovascular disease and diabetes: the role of polyphenol content in moderate consumption of wine and olive oil. Nutrients, 11(11), 2833. https://doi.org/10.3390/nu11112833
   PubMed Web of Science ®Google Scholar
• Drinda, S., Grundler, F., Neumann, T., Lehmann, T., Steckhan, N., Michalsen, A., & Wilhelmi de Toledo, F. (2019). Effects of periodic fasting on fatty liver index – A prospective observational study. Nutrients, 11(11), 2601. https://doi.org/10.3390/nu11112601
   PubMed Web of Science ®Google Scholar
• Duarte, S. M. B., Stefano, J. T., Vanni, D. S., Carrilho, F. J., & Oliveira, C. P. M. S. (2019). Impact of current diet at the risk of non-alcoholic fatty liver disease (NAFLD). Arquivos de Gastroenterologia, 56(4), 431–439. https://doi.org/10.1590/S0004-2803.201900000-67
   PubMedGoogle Scholar
• Dyson, J. K., Anstee, Q. M., & McPherson, S. (2015). Republished: Non-alcoholic fatty liver disease: a practical approach to treatment. Postgraduate Medical Journal, 91(1072), 92–101. https://doi.org/10.1136/postgradmedj-2013-100404rep
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. (2016). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Journal of Hepatology, 64:1388–1402.
   PubMed Web of Science ®Google Scholar
• Fan, J.-G., & Cao, H.-X. (2013). Role of diet and nutritional management in non-alcoholic fatty liver disease: Dietary management in fatty liver. Journal of Gastroenterology and Hepatology, 28(S4), 81–87. https://doi.org/10.1111/jgh.12244
   PubMedGoogle Scholar
• Foster, T., Budoff, M. J., Saab, S., Ahmadi, N., Gordon, C., & Guerci, A. D. (2011). Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial. The American Journal of Gastroenterology, 106(1), 71–77. https://doi.org/10.1038/ajg.2010.299
   PubMed Web of Science ®Google Scholar
• Galisteo, M., Duarte, J., & Zarzuelo, A. (2008). Effects of dietary fibers on disturbances clustered in the metabolic syndrome. The Journal of Nutritional Biochemistry, 19(2), 71–84. https://doi.org/10.1016/j.jnutbio.2007.02.009
   PubMed Web of Science ®Google Scholar
• Gamil, N. M. B., El Agaty, S. M., Megahed, G. K., Mansour, R. S., & Abdel-Latif, M. S. (2021). Reversion to a regular diet with alternate day fasting can cure grade-I non-alcoholic fatty liver disease (NAFLD) in high fructose-intake-associated metabolic syndrome. Egyptian Liver Journal, 11, 60.
   Google Scholar
• Glen, J., Floros, L., Day, C., & Pryke, R. (2016). Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance. BMJ, 354, i4428. https://doi.org/10.1136/bmj.i4428
   PubMedGoogle Scholar
• Goel, A., Gupta, M., & Aggarwal, R. (2014). Gut microbiota and liver disease. Journal of Gastroenterology and Hepatology, 29(6), 1139–1148. https://doi.org/10.1111/jgh.12556
   PubMed Web of Science ®Google Scholar
• Gorman, S., Black, L., Feelisch, M., Hart, P., & Weller, R. (2015). Can Skin Exposure to Sunlight Prevent Liver Inflammation? Nutrients, 7(5), 3219–3239. https://doi.org/10.3390/nu7053219
   PubMed Web of Science ®Google Scholar
• Gosal, H., Kaur, H., Chakwop Ngassa, H., Elmenawi, K. A., Anil, V., & Mohammed, L. (2021). The significance of the Mediterranean diet in the management of non-alcoholic fatty liver disease: a systematic review. Cureus, 13(6), e15618. https://doi.org/10.7759/cureus.15618
   PubMed Web of Science ®Google Scholar
• Gotsis, E., Anagnostis, P., Mariolis, A., Vlachou, A., Katsiki, N., & Karagiannis, A. (2015). Health benefits of the Mediterranean Diet: an update of research over the last 5 years. Angiology, 66(4), 304–318. https://doi.org/10.1177/0003319714532169
   PubMed Web of Science ®Google Scholar
• Hallberg, S. J., McKenzie, A. L., Williams, P. T., Bhanpuri, N. H., Peters, A. L., Campbell, W. W., Hazbun, T. L., Volk, B. M., McCarter, J. P., Phinney, S. D., & Volek, J. S. (2018). Effectiveness and safety of a novel care model for the management of type 2 diabetes at 1 year: an open-label, non-randomized, controlled study. Diabetes Therapy, 9(2), 583–612. https://doi.org/10.1007/s13300-018-0373-9
   PubMed Web of Science ®Google Scholar
• Hallsworth, K., & Adams, L. A. (2019). Lifestyle modification in NAFLD/NASH: Facts and figures. JHEP Reports, 1(6), 468–479. https://doi.org/10.1016/j.jhepr.2019.10.008
   PubMedGoogle Scholar
• Han, M. A. T., Yu, Q., Tafesh, Z., & Pyrsopoulos, N. (2021). Diversity in nafld: A review of manifestations of nonalcoholic fatty liver disease in different ethnicities globally. Journal of Clinical and Translational Hepatology, 9(1), 71–80. https://doi.org/10.14218/JCTH.2020.00082
   PubMed Web of Science ®Google Scholar
• Hardy, T., Anstee, Q. M., & Day, C. P. (2015). Nonalcoholic fatty liver disease: New treatments. Current Opinion in Gastroenterology, 31(3), 175–183. https://doi.org/10.1097/MOG.0000000000000175
   PubMed Web of Science ®Google Scholar
• Hassan, M., Shah, Y., Tariq, A., Qasim, Z., Jabbar, S., & Fatima, M. (2021). A widespread acquired ailment, nonalcoholic fatty liver disease; its approaches related to nutritional therapy. Acta Scientifci Nutritional Health, 5(10), 36–50. https://doi.org/10.31080/ASNH.2020.05.0930
   Google Scholar
• Hassani Zadeh, S., Mansoori, A., & Hosseinzadeh, M. (2020). Relationship between dietary patterns and non-alcoholic fatty liver disease: A systematic review and meta-analysis. Journal of Gastroenterology and Hepatology, 36(6), 1470–1478. https://doi.org/10.1111/jgh.15363
   PubMed Web of Science ®Google Scholar
• Haufe, S., Engeli, S., Kast, P., Böhnke, J., Utz, W., Haas, V., Hermsdorf, M., Mähler, A., Wiesner, S., Birkenfeld, A. L., Sell, H., Otto, C., Mehling, H., Luft, F. C., Eckel, J., Schulz-Menger, J., Boschmann, M., & Jordan, J. (2011). Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects. Hepatology, 53(5), 1504–1514. https://doi.org/10.1002/hep.24242
   PubMed Web of Science ®Google Scholar
• Havel, P. J. (2005). Dietary fructose: Implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutrition Reviews, 63(5), 133–157. https://doi.org/10.1111/j.1753-4887.2005.tb00132.x
   PubMed Web of Science ®Google Scholar
• Hekmatdoost, A., Shamsipour, A., Meibodi, M., Gheibizadeh, N., Eslamparast, T., & Poustchi, H. (2016). Adherence to the dietary approaches to stop hypertension (DASH) and risk of nonalcoholic fatty liver disease. International Journal of Food Sciences and Nutrition, 67(8), 1024–1029. https://doi.org/10.1080/09637486.2016.1210101
   PubMed Web of Science ®Google Scholar
• Hollingsworth, K. G., Abubacker, M. Z., Joubert, I., Allison, M. E. D., & Lomas, D. J. (2006). Low-carbohydrate diet induced reduction of hepatic lipid content observed with a rapid non-invasive MRI technique. The British Journal of Radiology, 79(945), 712–715. https://doi.org/10.1259/bjr/23166141
   PubMed Web of Science ®Google Scholar
• Holmer, M., Lindqvist, C., Petersson, S., Moshtaghi-Svensson, J., Tillander, V., Brismar, T. B., Hagström, H., & Stål, P. (2021). Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet – A randomized controlled trial. JHEP Reports, 3(3), 100256. https://doi.org/10.1016/j.jhepr.2021.100256
   PubMedGoogle Scholar
• Hormoznejad, R., Mohammad Shahi, M., Rahim, F., Helli, B., Alavinejad, P., & Sharhani, A. (2020). Combined cranberry supplementation and weight loss diet in non-alcoholic fatty liver disease: a double-blind placebo-controlled randomized clinical trial. International Journal of Food Sciences and Nutrition, 71(8), 991–1000. https://doi.org/10.1080/09637486.2020.1746957
   PubMed Web of Science ®Google Scholar
• Hu, F. (2002). Dietary pattern analysis: a new direction in nutritional epidemiology. Current Opinion in Lipidology, 13(1), 3–9. https://doi.org/10.1097/00041433-200202000-00002
   PubMed Web of Science ®Google Scholar
• Hyde, P. N., Sapper, T. N., Crabtree, C. D., LaFountain, R. A., Bowling, M. L., Buga, A., Fell, B., McSwiney, F. T., Dickerson, R. M., Miller, V. J., Scandling, D., Simonetti, O. P., Phinney, S. D., Kraemer, W. J., King, S. A., Krauss, R. M., & Volek, J. S. (2019). Dietary carbohydrate restriction improves metabolic syndrome independent of weight loss. JCI Insight, 4(12), e128308. https://doi.org/10.1172/jci.insight.128308
   PubMed Web of Science ®Google Scholar
• Johari, M. I., Yusoff, K., Haron, J., Nadarajan, C., Ibrahim, K. N., Wong, M. S., Hafidz, M. I. A., Chua, B. E., Hamid, N., Arifin, W. N., Ma, Z. F., & Lee, Y. Y. (2019). A randomized controlled trial on the effectiveness and adherence of modified alternate-day calorie restriction in improving activity of non-alcoholic fatty liver disease. Scientific Reports, 9(1), 11232. https://doi.org/10.1038/s41598-019-47763-8
   PubMedGoogle Scholar
• Kastorini, C.-M., Milionis, H. J., Esposito, K., Giugliano, D., Goudevenos, J. A., & Panagiotakos, D. B. (2011). The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534, 906 individuals. Journal of the American College of Cardiology, 57(11), 1299–1313. https://doi.org/10.1016/j.jacc.2010.09.073
   PubMed Web of Science ®Google Scholar
• Katsiki, N., Pérez-Martínez, P., & Lopez-Miranda, J. (2021). Olive oil intake and cardiovascular disease prevention: ‘seek and you shall find’. Current Cardiology Reports, 23(6), 64. https://doi.org/10.1007/s11886-021-01496-1
   PubMed Web of Science ®Google Scholar
• Kawaguchi, T., Charlton, M., Kawaguchi, A., Yamamura, S., Nakano, D., Tsutsumi, T., Zafer, M., & Torimura, T. (2021). Effects of Mediterranean diet in patients with nonalcoholic fatty liver disease: a systematic review meta-analysis, and meta-regression analysis of randomized controlled trials. Seminars in Liver Disease, 41(3), 225–234. https://doi.org/10.1055/s-0041-1723751
   PubMedGoogle Scholar
• Kawanaka, M., Mahmood, S., Niiyama, G., Izumi, A., Kamei, A., Ikeda, H., Suehiro, M., Togawa, K., Sasagawa, T., Okita, M., Nakamura, H., Yodoi, J., & Yamada, G. (2004). Control of oxidative stress and reduction in biochemical markers by Vitamin E treatment in patients with nonalcoholic steatohepatitis: a pilot study. Hepatology Research, 29(1), 39–41. https://doi.org/10.1016/j.hepres.2004.02.002
   PubMed Web of Science ®Google Scholar
• Kawasaki, T., Igarashi, K., Koeda, T., Sugimoto, K., Nakagawa, K., Hayashi, S., Yamaji, R., Inui, H., Fukusato, T., & Yamanouchi, T. (2009). Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic steatosis. The Journal of Nutrition, 139(11), 2067–2071. https://doi.org/10.3945/jn.109.105858
   PubMed Web of Science ®Google Scholar
• Kirk, E., Reeds, D. N., Finck, B. N., Mayurranjan, M. S., Patterson, B. W., & Klein, S. (2009). Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology, 136(5), 1552–1560.
   Google Scholar
• Kirk, E., Reeds, D. N., Finck, B. N., Mayurranjan, S. M., Patterson, B. W., & Klein, S. (2009). Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology, 136(5), 1552–1560. https://doi.org/10.1053/j.gastro.2009.01.048
   PubMed Web of Science ®Google Scholar
• Kong, L. C., Holmes, B. A., Cotillard, A., Habi-Rachedi, F., Brazeilles, R., Gougis, S., Gausserès, N., Cani, P. D., Fellahi, S., Bastard, J.-P., Kennedy, S. P., Doré, J., Ehrlich, S. D., Zucker, J.-D., Rizkalla, S. W., & Clément, K. (2014). Dietary patterns differently associate with inflammation and gut microbiota in overweight and obese subjects. PLOS One, 9(10), e109434. https://doi.org/10.1371/journal.pone.0109434
   PubMed Web of Science ®Google Scholar
• Kontogianni, M. D., Tileli, N., Margariti, A., Georgoulis, M., Deutsch, M., Tiniakos, D., Fragopoulou, E., Zafiropoulou, R., Manios, Y., & Papatheodoridis, G. (2014). Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease. Clinical Nutrition, 33(4), 678–683. https://doi.org/10.1016/j.clnu.2013.08.014
   PubMed Web of Science ®Google Scholar
• Lai, H. S., Lin, W. H., Chen, P. R., Wu, H. C., Lee, P. H., & Chen, W. J. (2005). Effects of a High Fiber Diet on Hepatocyte Apoptosis and Liver Regeneration After Partial Hepatectomy in Rats With Fatty Liver. Journal of Parenteral and Enteral Nutrition, 29(6), 401–407.
   PubMed Web of Science ®Google Scholar
• Larson-Meyer, D. E., Newcomer, B. R., Heilbronn, L. K., Volaufova, J., Smith, S. R., Alfonso, A. J., Lefevre, M., Rood, J. C., Williamson, D. A., Ravussin, E., & Team, T. P. C. (2008). Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. Obesity, 16(6), 1355–1362. https://doi.org/10.1038/oby.2008.201
   PubMed Web of Science ®Google Scholar
• Lavine, J. E. (2000). Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. The Journal of Pediatrics, 136(6), 734–738. https://doi.org/10.1016/S0022-3476(00)05040-X
   PubMed Web of Science ®Google Scholar
• Lavine, J. E., Schwimmer, J. B., Van Natta, M. L., Molleston, J. P., Murray, K. F., Rosenthal, P., Abrams, S. H., Scheimann, A. O., Sanyal, A. J., Chalasani, N., Tonascia, J., Ünalp, A., Clark, J. M., Brunt, E. M., Kleiner, D. E., Hoofnagle, J. H., … & Robuck, P. R. (2011). Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA, 305(16), 1659–1668. https://doi.org/10.1001/jama.2011.520
   PubMed Web of Science ®Google Scholar
• Lê, K.-A., Ith, M., Kreis, R., Faeh, D., Bortolotti, M., Tran, C., Boesch, C., & Tappy, L. (2009). Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. The American Journal of Clinical Nutrition, 89(6), 1760–1765. https://doi.org/10.3945/ajcn.2008.27336
   PubMed Web of Science ®Google Scholar
• Leaf, A., & Lansdowne, Z. (2014). Vitamins-conventional uses and new insights. World Review of Nutrition and Dietetics, 110, 152–166. https://doi.org/10.1159/000358464
   PubMed Web of Science ®Google Scholar
• Lee, S.-W., Baek, S.-M., Kang, K.-K., Lee, A.-R., Kim, T.-U., Choi, S.-K., Roh, Y.-S., Hong, I.-H., Park, S.-J., Kim, T.-H., Jeong, K.-S., & Park, J.-K. (2021). Vitamin C deficiency inhibits nonalcoholic fatty liver disease progression through impaired de novo lipogenesis. The American Journal of Pathology, 191(9), 1550–1563. https://doi.org/10.1016/j.ajpath.2021.05.020
   PubMed Web of Science ®Google Scholar
• León-Mimila, P., Villamil-Ramírez, H., Li, X. S., Shih, D. M., Hui, S. T., Ocampo-Medina, E., López-Contreras, B., Morán-Ramos, S., Olivares-Arevalo, M., Grandini-Rosales, P., Macías-Kauffer, L., González-González, I., Hernández-Pando, R., Gómez-Pérez, F., Campos-Pérez, F., Aguilar-Salinas, C., Larrieta-Carrasco, E., Villarreal-Molina, T., Wang, Z., … Canizales-Quinteros, S. (2021). Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes. Diabetes & Metabolism, 47(2), 101183. https://doi.org/10.1016/j.diabet.2020.07.010
   PubMed Web of Science ®Google Scholar
• Li, J., Bai, W.-P., Jiang, B., Bai, L.-R., Gu, B., Yan, S.-X., Li, F.-Y., & Huang, B. (2021). Ketogenic diet in women with polycystic ovary syndrome and liver dysfunction who are obese: a randomized, open-label, parallel-group, controlled pilot trial. The Journal of Obstetrics and Gynaecology Research, 47(3), 1145–1152. https://doi.org/10.1111/jog.14650
   PubMed Web of Science ®Google Scholar
• Luukkonen, P. K., Dufour, S., Lyu, K., Zhang, X.-M., Hakkarainen, A., Lehtimäki, T. E., Cline, G. W., Petersen, K. F., Shulman, G. I., & Yki-Järvinen, H. (2020). Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease. Proceedings of the National Academy of Sciences of the United States of America, 117(13), 7347–7354. https://doi.org/10.1073/pnas.1922344117
   PubMed Web of Science ®Google Scholar
• Marchildon, F., St-Louis, C., Akter, R., Roodman, V., & Wiper-Bergeron, N. L. (2010). Transcription factor Smad3 is required for the inhibition of adipogenesis by retinoic acid. The Journal of Biological Chemistry, 285(17), 13274–13284. https://doi.org/10.1074/jbc.M109.054536
   PubMed Web of Science ®Google Scholar
• Mardinoglu, A., Wu, H., Bjornson, E., Zhang, C., Hakkarainen, A., Räsänen, S. M., Lee, S., Mancina, R. M., Bergentall, M., Pietiläinen, K. H., Söderlund, S., Matikainen, N., Ståhlman, M., Bergh, P.-O., Adiels, M., Piening, B. D., Granér, M., Lundbom, N., Williams, K. J., … Borén, J. (2018). An integrated understanding of the rapid metabolic benefits of a carbohydrate-restricted diet on hepatic steatosis in humans. Cell Metabolism, 27(3), 559–571.e5. https://doi.org/10.1016/j.cmet.2018.01.005
   PubMed Web of Science ®Google Scholar
• Mehta, K., Van Thiel, D. H., Shah, N., & Mobarhan, S. (2002). Nonalcoholic fatty liver disease: Pathogenesis and the role of antioxidants. Nutrition Reviews, 60(9), 289–293. https://doi.org/10.1301/002966402320387224
   PubMed Web of Science ®Google Scholar
• Mondul, A., Mancina, R. M., Merlo, A., Dongiovanni, P., Rametta, R., Montalcini, T., Valenti, L., Albanes, D., & Romeo, S. (2015). PNPLA3 I148M variant influences circulating retinol in adults with nonalcoholic fatty liver disease or obesity. The Journal of Nutrition, 145(8), 1687–1691. https://doi.org/10.3945/jn.115.210633
   PubMed Web of Science ®Google Scholar
• Moosavian, S. P., Arab, A., & Paknahad, Z. (2020). The effect of a Mediterranean diet on metabolic parameters in patients with non-alcoholic fatty liver disease: a systematic review of randomized controlled trials. Clinical Nutrition ESPEN, 35, 40–46. https://doi.org/10.1016/j.clnesp.2019.10.008
   PubMed Web of Science ®Google Scholar
• Mouzaki, M., & Allard, J. P. (2012). The role of nutrients in the development, progression, and treatment of nonalcoholic fatty liver disease. Journal of Clinical Gastroenterology, 46(6), 457–467. https://doi.org/10.1097/MCG.0b013e31824cf51e
   PubMed Web of Science ®Google Scholar
• Neuschwander-Tetri, B. A. (2017). Non-alcoholic fatty liver disease. BMC Medicine, 15(1), 45. https://doi.org/10.1186/s12916-017-0806-8
   PubMed Web of Science ®Google Scholar
• Oddy, W. H., Herbison, C. E., Jacoby, P., Ambrosini, G. L., O’Sullivan, T. A., Ayonrinde, O. T., Olynyk, J. K., Black, L. J., Beilin, L. J., Mori, T. A., Hands, B. P., & Adams, L. A. (2013). The Western dietary pattern is prospectively associated with nonalcoholic fatty liver disease in adolescence. The American Journal of Gastroenterology, 108(5), 778–785. https://doi.org/10.1038/ajg.2013.95
   PubMed Web of Science ®Google Scholar
• Ouyang, X., Cirillo, P., Sautin, Y., McCall, S., Bruchette, J. L., Diehl, A. M., Johnson, R. J., & Abdelmalek, M. F. (2008). Fructose consumption as a risk factor for non-alcoholic fatty liver disease. Journal of Hepatology, 48(6), 993–999. https://doi.org/10.1016/j.jhep.2008.02.011
   PubMed Web of Science ®Google Scholar
• Park, S. Y., Noureddin, M., Boushey, C., Wilkens, L. R., & Setiawan, V. W. (2020). Diet quality association with nonalcoholic fatty liver disease by cirrhosis status: the multiethnic cohort. Current Developments in Nutrition, 4(3), nzaa024. https://doi.org/10.1093/cdn/nzaa024
   PubMed Web of Science ®Google Scholar
• Parra-Vargas, M., Rodriguez-Echevarria, R., & Jimenez-Chillaron, J. C. (2020). Nutritional approaches for managing nonalcoholic fatty liver disease: an evidence-based review. Nutrients, 12(12), 3860. https://doi.org/10.3390/nu12123860
   PubMed Web of Science ®Google Scholar
• Pirazzi, C., Valenti, L., Motta, B. M., Pingitore, P., Hedfalk, K., Mancina, R. M., Burza, M. A., Indiveri, C., Ferro, Y., Montalcini, T., Maglio, C., Dongiovanni, P., Fargion, S., Rametta, R., Pujia, A., Andersson, L., Ghosal, S., Levin, M., Wiklund, O., … Romeo, S. (2014). PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells. Human Molecular Genetics, 23(15), 4077–4085. https://doi.org/10.1093/hmg/ddu121
   PubMed Web of Science ®Google Scholar
• Plaz Torres, M. C., Aghemo, A., Lleo, A., Bodini, G., Furnari, M., Marabotto, E., Miele, L., & Giannini, E. G. (2019). Mediterranean diet and NAFLD: what we know and questions that still need to be answered. Nutrients, 11(12), 2971. https://doi.org/10.3390/nu11122971
   PubMed Web of Science ®Google Scholar
• Portillo-Sanchez, P., & Cusi, K. (2016). Treatment of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus. Clinical Diabetes and Endocrinology, 2(1), 9. https://doi.org/10.1186/s40842-016-0027-7
   PubMedGoogle Scholar
• Pugliese, N., Plaz Torres, M. C., Petta, S., Valenti, L., Giannini, E. G., & Aghemo, A. (2021). Is there an ‘ideal’ diet for patients with NAFLD? European Journal of Clinical Investigation, 52(3), e13659. https://doi.org/10.1111/eci.13659
   PubMed Web of Science ®Google Scholar
• Puppala, J., Siddapuram, S. P., Akka, J., & Munshi, A. (2013). Genetics of nonalcoholic Fatty liver disease: an overview. Journal of Genetics and Genomics, 40(1), 15–22. https://doi.org/10.1016/j.jgg.2012.12.001
   PubMed Web of Science ®Google Scholar
• Recena Aydos, L., Aparecida do Amaral, L., Serafim de Souza, R., Jacobowski, A. C., Freitas Dos Santos, E., & Rodrigues Macedo, M. L. (2019). Nonalcoholic fatty liver disease induced by high-fat diet in C57bl/6 models. Nutrients, 11(12), 3067. https://doi.org/10.3390/nu11123067
   PubMed Web of Science ®Google Scholar
• Rehackova, L., Araújo‐Soares, V., Adamson, A. J., Steven, S., Taylor, R., & Sniehotta, F. F. (2017). Acceptability of a very‐low‐energy diet in Type 2 diabetes: patient experiences and behaviour regulation. Diabetic Medicine, 34(11), 1554–1567. https://doi.org/10.1111/dme.13426
   PubMed Web of Science ®Google Scholar
• Ritchie, L. D., Spector, P., Stevens, M. J., Schmidt, M. M., Schreiber, G. B., Striegel-Moore, R. H., Wang, M.-C., & Crawford, P. B. (2007). Dietary patterns in adolescence are related to adiposity in young adulthood in black and white females. The Journal of Nutrition, 137(2), 399–406. https://doi.org/10.1093/jn/137.2.399
   PubMed Web of Science ®Google Scholar
• Romero-Gómez, M., Zelber-Sagi, S., & Trenell, M. (2017). Treatment of NAFLD with diet, physical activity and exercise. Journal of Hepatology, 67(4), 829–846. https://doi.org/10.1016/j.jhep2017.05.016.
   PubMed Web of Science ®Google Scholar
• Ryan, M. C., Itsiopoulos, C., Thodis, T., Ward, G., Trost, N., Hofferberth, S., O’Dea, K., Desmond, P. V., Johnson, N. A., & Wilson, A. M. (2013). The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. Journal of Hepatology, 59(1), 138–143. https://doi.org/10.1016/j.jhep.2013.02.012
   PubMed Web of Science ®Google Scholar
• Saavedra, Y., Mena, V., & Priken, K. (2021). Effect of the Mediterranean diet on histological indicators and imaging tests in nonalcoholic fatty liver disease. Gastroenterologia y Hepatologia, 45(5), 350–360. https://doi.org/10.1016/j.gastrohep.2021.06.006
   PubMed Web of Science ®Google Scholar
• Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., Van Natta, M., Clark, J., Brunt, E. M., Kleiner, D. E., Hoofnagle, J. H., & Robuck, P. R. (2010). Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. The New England Journal of Medicine, 362(18), 1675–1685. https://doi.org/10.1056/NEJMoa0907929
   PubMed Web of Science ®Google Scholar
• Schwarz, J. M., Linfoot, P., Dare, D., & Aghajanian, K. (2003). Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. The American Journal of Clinical Nutrition, 77(1), 43–50. https://doi.org/10.1093/ajcn/77.1.43
   PubMed Web of Science ®Google Scholar
• Schwingshackl, L., Morze, J., & Hoffmann, G. (2020). Mediterranean diet and health status: active ingredients and pharmacological mechanisms. British Journal of Pharmacology, 177(6), 1241–1257. https://doi.org/10.1111/bph.14778
   PubMed Web of Science ®Google Scholar
• Senoo, H., Yoshikawa, K., Morii, M., Miura, M., Imai, K., & Mezaki, Y. (2010). Hepatic stellate cell (vitamin A‐storing cell) and its relative–past, present and future. Cell Biology International, 34(12), 1247–1272. https://doi.org/10.1042/CBI20100321
   PubMed Web of Science ®Google Scholar
• Soltani, S., Shirani, F., Chitsazi, M. J., & Salehi-Abargouei, A. (2016). The effect of dietary approaches to stop hypertension (DASH) diet on weight and body composition in adults: a systematic review and meta-analysis of randomized controlled clinical trials. Obesity Reviews, 17(5), 442–454. https://doi.org/10.1111/obr.12391
   PubMed Web of Science ®Google Scholar
• Sullivan, S. (2010). Implications of diet on nonalcoholic fatty liver disease. Current Opinion in Gastroenterology, 26(2), 160–164. https://doi.org/10.1097/MOG.0b013e3283358a58
   PubMed Web of Science ®Google Scholar
• Uesugi, T., Froh, M., Arteel, G. E., Bradford, B. U., Wheeler, M. D., Gäbele, E., Isayama, F., & Thurman, R. G. (2002). Role of Lipopolysaccharide-Binding Protein in Early Alcohol-Induced Liver Injury in Mice. Journal of Immunology, 168(6), 2963–2969. https://doi.org/10.4049/jimmunol.168.6.2963
   PubMed Web of Science ®Google Scholar
• Vajro, P., Mandato, C., Franzese, A., Ciccimarra, E., Lucariello, S., Savoia, M., Capuano, G., & Migliaro, F. (2004). Vitamin E treatment in pediatric obesity-related liver disease: a randomized study. Journal of Pediatric Gastroenterology and Nutrition, 38(1), 48–55. https://doi.org/10.1097/00005176-200401000-00012
   PubMed Web of Science ®Google Scholar
• Vancells Lujan, P., Viñas Esmel, E., & Sacanella Meseguer, E. (2021). Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the role of sugary food consumption and other dietary components in its development. Nutrients, 13(5), 1442. https://doi.org/10.3390/nu13051442
   PubMed Web of Science ®Google Scholar
• Viljanen, A. P. M., Iozzo, P., Borra, R., Kankaanpää, M., Karmi, A., Lautamäki, R., Järvisalo, M., Parkkola, R., Rönnemaa, T., Guiducci, L., Lehtimäki, T., Raitakari, O. T., Mari, A., & Nuutila, P. (2009). Effect of weight loss on liver free fatty acid uptake and hepatic insulin resistance. The Journal of Clinical Endocrinology and Metabolism, 94(1), 50–55. https://doi.org/10.1210/jc.2008-1689
   PubMed Web of Science ®Google Scholar
• Watanabe, M., Tozzi, R., Risi, R., Tuccinardi, D., Mariani, S., & Basciani, S. (2020). Beneficial effects of the ketogenic diet on nonalcoholic fatty liver disease: a comprehensive review of the literature. Obesity Reviews, 21, e13024.
   PubMed Web of Science ®Google Scholar
• Watzinger, C., Nonnenmacher, T., Grafetstätter, M., Sowah, S. A., Ulrich, C. M., Kauczor, H.-U., Kaaks, R., Schübel, R., Nattenmüller, J., & Kühn, T. (2020). Dietary factors in relation to liver fat content: a cross-sectional study. Nutrients, 12(3), 825. https://doi.org/10.3390/nu12030825
   PubMed Web of Science ®Google Scholar
• Wenfeng, Z., Yakun, W., Di, M., Jianping, G., Chuanxin, W., & Chun, H. (2014). Kupffer cells: increasingly significant role in nonalcoholic fatty liver disease. Annals of Hepatology. 13(5), 489–495. https://doi.org/10.1016/S1665-2681(19)31247-5
   PubMed Web of Science ®Google Scholar
• Westerbacka, J., Lammi, K., Häkkinen, A.-M., Rissanen, A., Salminen, I., Aro, A., & Yki-Järvinen, H. (2005). Dietary fat content modifies liver fat in overweight nondiabetic subjects. The Journal of Clinical Endocrinology and Metabolism, 90(5), 2804–2809. https://doi.org/10.1210/jc.2004-1983
   PubMed Web of Science ®Google Scholar
• Worm, N. (2020). Beyond body weight-loss: Dietary strategies targeting intrahepatic fat in NAFLD. Nutrients, 12(5), 1316. https://doi.org/10.3390/nu12051316
   PubMed Web of Science ®Google Scholar
• Xiao, M.-L., Lin, J.-S., Li, Y.-H., Liu, M., Deng, Y.-Y., Wang, C.-Y., & Chen, Y.-M. (2020). Adherence to the dietary approaches to stop hypertension (DASH) diet is associated with a lower presence of non-alcoholic fatty liver disease in middle-aged and elderly adults. Public Health Nutrition, 23(4), 674–682. https://doi.org/10.1017/S1368980019002568
   PubMed Web of Science ®Google Scholar
• Yasutake, K., Kohjima, M., Kotoh, K., Nakashima, M., Nakamuta, M., & Enjoji, M. (2014). Dietary habits and behaviors associated with nonalcoholic fatty liver disease. World Journal of Gastroenterology, 20(7), 1756–1767. https://doi.org/10.3748/wjg.v20.i7.1756
   PubMed Web of Science ®Google Scholar
• Yu, L., Yuan, M., & Wang, L. (2017). The effect of omega-3 unsaturated fatty acids on non-alcoholic fatty liver disease: A systematic review and meta-analysis of RCTs. Pakistan Journal of Medical Sciences, 33(4), 1022–1028. https://doi.org/10.12669/pjms.334.12315
   PubMed Web of Science ®Google Scholar
• Zelber-Sagi, S., Salomone, F., & Mlynarsky, L. (2017). The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms. Liver International, 37(7), 936–949. https://doi.org/10.1111/liv.13435
   PubMed Web of Science ®Google Scholar
• Zöhrer, E., Alisi, A., Jahnel, J., Mosca, A., Della Corte, C., Crudele, A., Fauler, G., & Nobili, V. (2017). Efficacy of docosahexaenoic acid–choline–vitamin E in paediatric NASH: a randomized controlled clinical trial. Applied Physiology, Nutrition, and Metabolism, 42(9), 948–954. https://doi.org/10.1139/apnm-2016-0689
   PubMed Web of Science ®Google Scholar